INNOVA CAPTAB
Back to Income Statement
|
INNOVA CAPTAB Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,081 Cr | ₹926 Cr | ₹801 Cr | ₹411 Cr | ₹373 Cr |
What is the latest Revenue of INNOVA CAPTAB ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,081 Cr |
| Mar2024 | ₹926 Cr |
| Mar2023 | ₹801 Cr |
| Mar2022 | ₹411 Cr |
| Mar2021 | ₹373 Cr |
How is Revenue of INNOVA CAPTAB Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,081 Cr | 16.72 | |
| Mar2024 | ₹926 Cr | 15.72 | |
| Mar2023 | ₹801 Cr | 94.94 | |
| Mar2022 | ₹411 Cr | 10.00 | |
| Mar2021 | ₹373 Cr | - | |
Compare Revenue of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹3,970.3 Cr | 8.4% | -0.5% | -1.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,855.0 Cr | 3.6% | 7% | 15.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,550.0 Cr | 1.1% | 5.8% | 14.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,906.0 Cr | 1.9% | 12.3% | 49.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,632.0 Cr | 1.8% | 5.9% | 14.8% | Stock Analytics | |
| CIPLA | ₹107,427.0 Cr | 1.6% | 0.2% | -5.4% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | 8.4% |
-0.5% |
-1.4% |
| SENSEX | -2.9% |
-8% |
5.3% |
You may also like the below Video Courses